Form 4 for OFIX Orthofix Medical Inc.
Accepted 2024-01-10 00:00:00 ET · period of report 2024-01-08 · accession 0001209191-24-001366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-10 | 2024-01-08 | OFIX | Calafiore Massimo | Pres, CEO | A - Grant | $13.29 | +141.1K | 141.1K | New | +$1.88M |
| D | 2024-01-10 | 2024-01-08 | OFIX | Calafiore Massimo | Pres, CEO | A - Grant | $0.00 | -392.0K | 392.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-08 | A | A | 141,084 | $13.29 | 141,084 | D | — | — | (F1) The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-01-08 | A | D | 392,005 | $0.00 | 392,005 | D | $13.29 · — to 2031-01-08 | 392,005 Common Stock | (F2) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date, subject in each case to an additional vesting requirement related to the performance of the Company's common stock. |